Cargando…
Clinical and Pharmacological Investigation of Myotoxicity in Sri Lankan Russell’s Viper (Daboia russelii) Envenoming
BACKGROUND: Sri Lankan Russell’s viper (Daboia russelii) envenoming is reported to cause myotoxicity and neurotoxicity, which are different to the effects of envenoming by most other populations of Russell’s vipers. This study aimed to investigate evidence of myotoxicity in Russell’s viper envenomin...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135039/ https://www.ncbi.nlm.nih.gov/pubmed/27911900 http://dx.doi.org/10.1371/journal.pntd.0005172 |
_version_ | 1782471558761021440 |
---|---|
author | Silva, Anjana Johnston, Christopher Kuruppu, Sanjaya Kneisz, Daniela Maduwage, Kalana Kleifeld, Oded Smith, A. Ian Siribaddana, Sisira Buckley, Nicholas A. Hodgson, Wayne C. Isbister, Geoffrey K. |
author_facet | Silva, Anjana Johnston, Christopher Kuruppu, Sanjaya Kneisz, Daniela Maduwage, Kalana Kleifeld, Oded Smith, A. Ian Siribaddana, Sisira Buckley, Nicholas A. Hodgson, Wayne C. Isbister, Geoffrey K. |
author_sort | Silva, Anjana |
collection | PubMed |
description | BACKGROUND: Sri Lankan Russell’s viper (Daboia russelii) envenoming is reported to cause myotoxicity and neurotoxicity, which are different to the effects of envenoming by most other populations of Russell’s vipers. This study aimed to investigate evidence of myotoxicity in Russell’s viper envenoming, response to antivenom and the toxins responsible for myotoxicity. METHODOLOGY AND FINDINGS: Clinical features of myotoxicity were assessed in authenticated Russell’s viper bite patients admitted to a Sri Lankan teaching hospital. Toxins were isolated using high-performance liquid chromatography. In-vitro myotoxicity of the venom and toxins was investigated in chick biventer nerve-muscle preparations. Of 245 enrolled patients, 177 (72.2%) had local myalgia and 173 (70.6%) had local muscle tenderness. Generalized myalgia and muscle tenderness were present in 35 (14.2%) and 29 (11.8%) patients, respectively. Thirty-seven patients had high (>300 U/l) serum creatine kinase (CK) concentrations in samples 24h post-bite (median: 666 U/l; maximum: 1066 U/l). Peak venom and 24h CK concentrations were not associated (Spearman’s correlation; p = 0.48). The 24h CK concentrations differed in patients without myotoxicity (median 58 U/l), compared to those with local (137 U/l) and generalised signs/symptoms of myotoxicity (107 U/l; p = 0.049). Venom caused concentration-dependent inhibition of direct twitches in the chick biventer cervicis nerve-muscle preparation, without completely abolishing direct twitches after 3 h even at 80 μg/ml. Indian polyvalent antivenom did not prevent in-vitro myotoxicity at recommended concentrations. Two phospholipase A(2) toxins with molecular weights of 13kDa, U1-viperitoxin-Dr1a (19.2% of venom) and U1-viperitoxin-Dr1b (22.7% of venom), concentration dependently inhibited direct twitches in the chick biventer cervicis nerve-muscle preparation. At 3 μM, U1-viperitoxin-Dr1a abolished twitches, while U1-viperitoxin-Dr1b caused 70% inhibition of twitch force after 3h. Removal of both toxins from whole venom resulted in no in-vitro myotoxicity. CONCLUSION: The study shows that myotoxicity in Sri Lankan Russell’s viper envenoming is mild and non-life threatening, and due to two PLA(2) toxins with weak myotoxic properties. |
format | Online Article Text |
id | pubmed-5135039 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-51350392016-12-21 Clinical and Pharmacological Investigation of Myotoxicity in Sri Lankan Russell’s Viper (Daboia russelii) Envenoming Silva, Anjana Johnston, Christopher Kuruppu, Sanjaya Kneisz, Daniela Maduwage, Kalana Kleifeld, Oded Smith, A. Ian Siribaddana, Sisira Buckley, Nicholas A. Hodgson, Wayne C. Isbister, Geoffrey K. PLoS Negl Trop Dis Research Article BACKGROUND: Sri Lankan Russell’s viper (Daboia russelii) envenoming is reported to cause myotoxicity and neurotoxicity, which are different to the effects of envenoming by most other populations of Russell’s vipers. This study aimed to investigate evidence of myotoxicity in Russell’s viper envenoming, response to antivenom and the toxins responsible for myotoxicity. METHODOLOGY AND FINDINGS: Clinical features of myotoxicity were assessed in authenticated Russell’s viper bite patients admitted to a Sri Lankan teaching hospital. Toxins were isolated using high-performance liquid chromatography. In-vitro myotoxicity of the venom and toxins was investigated in chick biventer nerve-muscle preparations. Of 245 enrolled patients, 177 (72.2%) had local myalgia and 173 (70.6%) had local muscle tenderness. Generalized myalgia and muscle tenderness were present in 35 (14.2%) and 29 (11.8%) patients, respectively. Thirty-seven patients had high (>300 U/l) serum creatine kinase (CK) concentrations in samples 24h post-bite (median: 666 U/l; maximum: 1066 U/l). Peak venom and 24h CK concentrations were not associated (Spearman’s correlation; p = 0.48). The 24h CK concentrations differed in patients without myotoxicity (median 58 U/l), compared to those with local (137 U/l) and generalised signs/symptoms of myotoxicity (107 U/l; p = 0.049). Venom caused concentration-dependent inhibition of direct twitches in the chick biventer cervicis nerve-muscle preparation, without completely abolishing direct twitches after 3 h even at 80 μg/ml. Indian polyvalent antivenom did not prevent in-vitro myotoxicity at recommended concentrations. Two phospholipase A(2) toxins with molecular weights of 13kDa, U1-viperitoxin-Dr1a (19.2% of venom) and U1-viperitoxin-Dr1b (22.7% of venom), concentration dependently inhibited direct twitches in the chick biventer cervicis nerve-muscle preparation. At 3 μM, U1-viperitoxin-Dr1a abolished twitches, while U1-viperitoxin-Dr1b caused 70% inhibition of twitch force after 3h. Removal of both toxins from whole venom resulted in no in-vitro myotoxicity. CONCLUSION: The study shows that myotoxicity in Sri Lankan Russell’s viper envenoming is mild and non-life threatening, and due to two PLA(2) toxins with weak myotoxic properties. Public Library of Science 2016-12-02 /pmc/articles/PMC5135039/ /pubmed/27911900 http://dx.doi.org/10.1371/journal.pntd.0005172 Text en © 2016 Silva et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Silva, Anjana Johnston, Christopher Kuruppu, Sanjaya Kneisz, Daniela Maduwage, Kalana Kleifeld, Oded Smith, A. Ian Siribaddana, Sisira Buckley, Nicholas A. Hodgson, Wayne C. Isbister, Geoffrey K. Clinical and Pharmacological Investigation of Myotoxicity in Sri Lankan Russell’s Viper (Daboia russelii) Envenoming |
title | Clinical and Pharmacological Investigation of Myotoxicity in Sri Lankan Russell’s Viper (Daboia russelii) Envenoming |
title_full | Clinical and Pharmacological Investigation of Myotoxicity in Sri Lankan Russell’s Viper (Daboia russelii) Envenoming |
title_fullStr | Clinical and Pharmacological Investigation of Myotoxicity in Sri Lankan Russell’s Viper (Daboia russelii) Envenoming |
title_full_unstemmed | Clinical and Pharmacological Investigation of Myotoxicity in Sri Lankan Russell’s Viper (Daboia russelii) Envenoming |
title_short | Clinical and Pharmacological Investigation of Myotoxicity in Sri Lankan Russell’s Viper (Daboia russelii) Envenoming |
title_sort | clinical and pharmacological investigation of myotoxicity in sri lankan russell’s viper (daboia russelii) envenoming |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135039/ https://www.ncbi.nlm.nih.gov/pubmed/27911900 http://dx.doi.org/10.1371/journal.pntd.0005172 |
work_keys_str_mv | AT silvaanjana clinicalandpharmacologicalinvestigationofmyotoxicityinsrilankanrussellsviperdaboiarusseliienvenoming AT johnstonchristopher clinicalandpharmacologicalinvestigationofmyotoxicityinsrilankanrussellsviperdaboiarusseliienvenoming AT kuruppusanjaya clinicalandpharmacologicalinvestigationofmyotoxicityinsrilankanrussellsviperdaboiarusseliienvenoming AT kneiszdaniela clinicalandpharmacologicalinvestigationofmyotoxicityinsrilankanrussellsviperdaboiarusseliienvenoming AT maduwagekalana clinicalandpharmacologicalinvestigationofmyotoxicityinsrilankanrussellsviperdaboiarusseliienvenoming AT kleifeldoded clinicalandpharmacologicalinvestigationofmyotoxicityinsrilankanrussellsviperdaboiarusseliienvenoming AT smithaian clinicalandpharmacologicalinvestigationofmyotoxicityinsrilankanrussellsviperdaboiarusseliienvenoming AT siribaddanasisira clinicalandpharmacologicalinvestigationofmyotoxicityinsrilankanrussellsviperdaboiarusseliienvenoming AT buckleynicholasa clinicalandpharmacologicalinvestigationofmyotoxicityinsrilankanrussellsviperdaboiarusseliienvenoming AT hodgsonwaynec clinicalandpharmacologicalinvestigationofmyotoxicityinsrilankanrussellsviperdaboiarusseliienvenoming AT isbistergeoffreyk clinicalandpharmacologicalinvestigationofmyotoxicityinsrilankanrussellsviperdaboiarusseliienvenoming |